Vanin-1 T26I polymorphism, hypertension and cardiovascular events in two large urban-based prospective studies in Swedes.

[1]  M. Montagnana,et al.  Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes , 2010, Pharmacogenetics and genomics.

[2]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[3]  Andrew D. Johnson,et al.  Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.

[4]  F. Dunn,et al.  Hypertension and myocardial ischemia. , 2009, The Medical clinics of North America.

[5]  B. Zachariah,et al.  Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials , 2009, Angiology.

[6]  D. Levy,et al.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure , 2009, Nature Genetics.

[7]  R. Touyz,et al.  Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. , 2009, Current opinion in nephrology and hypertension.

[8]  G. Lippi,et al.  The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure , 2008, Hypertension.

[9]  G. Lippi,et al.  The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle‐aged Swedish individuals , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[10]  J. Webster,et al.  Glutathione S-transferase variants and hypertension , 2008, Journal of hypertension.

[11]  Y. Kokubo,et al.  Associations of Hypertension and Its Complications with Variations in the Xanthine Dehydrogenase Gene , 2008, Hypertension Research.

[12]  A. Dominiczak,et al.  Targeting reactive oxygen species in hypertension. , 2008, Antioxidants & redox signaling.

[13]  R. Cooper,et al.  Admixture Mapping Provides Evidence of Association of the VNN1 Gene with Hypertension , 2007, PloS one.

[14]  L. Almasy,et al.  Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes , 2007, Nature Genetics.

[15]  G. Berglund,et al.  Blood Pressure in Relation to the Incidence of Cerebral Infarction and Intracerebral Hemorrhage: Hypertensive Hemorrhage: Debated Nomenclature Is Still Relevant , 2007, Stroke.

[16]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[17]  D. Corella,et al.  A novel CYBA variant, the –675A/T polymorphism, is associated with essential hypertension , 2007, Journal of hypertension.

[18]  D. Corella,et al.  Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels , 2007, Pharmacogenetics and genomics.

[19]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[20]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[21]  G. Lip,et al.  Oxidative stress and hypertension , 2006, International journal of clinical practice.

[22]  J. Díez,et al.  The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension , 2006, Journal of hypertension.

[23]  P. Pagano,et al.  Hydrogen Peroxide as a Paracrine Vascular Mediator: Regulation and Signaling Leading to Dysfunction , 2006, Experimental biology and medicine.

[24]  L. Muglia,et al.  Vascular respiratory uncoupling increases blood pressure and atherosclerosis , 2005, Nature.

[25]  Hongyu Zhao,et al.  A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA , 2004, Science.

[26]  J. Imbert,et al.  Vanin-1−/− Mice Exhibit a Glutathione-Mediated Tissue Resistance to Oxidative Stress , 2004, Molecular and Cellular Biology.

[27]  Fengzhu Sun,et al.  Mitochondrial genome mutations in hypertensive individuals. , 2004, American journal of hypertension.

[28]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[29]  S. Harrap,et al.  Antihypertensive Treatments Obscure Familial Contributions to Blood Pressure Variation , 2003, Hypertension.

[30]  B. Maras,et al.  Pantetheinase activity of membrane‐bound Vanin‐1: lack of free cysteamine in tissues of Vanin‐1 deficient mice , 2000, FEBS letters.

[31]  K. Livak,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.

[32]  J. Hecht,et al.  Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation , 1998, Neurology.

[33]  K. Eriksson,et al.  Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project , 1996, Journal of internal medicine.

[34]  G. Berglund,et al.  Design and feasibility , 1993 .

[35]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[36]  H. Lepidi,et al.  Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores. , 2004, The Journal of clinical investigation.

[37]  T Foitzi,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .

[38]  G. Berglund,et al.  The Malmo Diet and Cancer Study. Design and feasibility. , 1993, Journal of internal medicine.